Skip to main content
PTCT logo

PTCT · Ptc Therapeutics, Inc.

Track PTCT — free
$71.70 -0.27 (-0.38%) At close · Aug 14
Market Cap
$5.98B
Shares
83.46M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2019
Executive Total
Stuart Peltz $7,759,441
Marcio Souza $3,709,523
Neil Almstead $2,518,769
Mark E. Boulding $2,509,994
Emily Hill $2,336,648
Christine Utter $1,700,118
Fiscal 2018
Executive Total
Stuart Peltz $4,016,735
Marcio Souza $1,945,002
Neil Almstead $1,609,441
Mark E. Boulding $1,604,903
Christine Utter $1,148,789
Fiscal 2017
Executive Total
Stuart Peltz $2,172,683
Marcio Souza $1,524,266
Mark E. Boulding $1,121,909
Neil Almstead $951,918

Executive changes

Person Change Filed
Hege Sollie-Zetlmayer Appointed 2026-07-30
Alethia Young Resigned 2026-06-09
Jessica Chutter Appointed 2026-03-25
Pierre Gravier Appointed 2023-07-17
Emily Hill Terminated 2023-05-23
Dr. Stuart W. Peltz Retired 2023-03-24
Dr. Matthew B. Klein Appointed 2023-03-24
Dr. Stuart W. Peltz Retired 2023-03-24
Dr. Matthew B. Klein Appointed 2023-03-24
Dawn Svoronos Resigned 2022-12-06
Alethia Young Appointed 2022-06-09
Dawn Svoronos Appointed 2022-06-09
David P. Southwell Appointed 2022-06-09
Allan Jacobson Appointed 2022-06-09
Key facts CIK 1070081 CUSIP 69366J200 13F (30d) 377 filings 348 filers Visit website Investor relations